The Ludwig Boltzmann Institute Applied Diagnostics in Vienna, Austria, follows a new dual biomarker concept for tumor diagnosis.
The focus of the institute lies on the development of non-invasive diagnostic methods combining molecular epigenetic and genetic signatures with molecular imaging biomarkers for PET and SPECT analysis.
The combination of these two methods will allow for improved functional, spatial and temporal assessment of tumor load and molecular tumor characterization.
We currently have an open position (100%) with immediate start date for a lab technician for the preclinical biological evaluation of novel, radioactive labelled, tumor-targeting molecules within the institute’s program line Imaging Biomarkers.
The candidate will work in a stimulating, interdisciplinary environment (tumor biology, pathology, nuclear medicine, chemistry, pharmacology and health economics) at the General Hospital of Vienna and the Medical University Vienna.
Skills / Qualifications